Sapporo Clinical Laboratory Balance Sheet Health
Financial Health criteria checks 5/6
Sapporo Clinical Laboratory has a total shareholder equity of ¥11.2B and total debt of ¥1.6B, which brings its debt-to-equity ratio to 14.3%. Its total assets and total liabilities are ¥16.7B and ¥5.5B respectively. Sapporo Clinical Laboratory's EBIT is ¥535.0M making its interest coverage ratio 267.5. It has cash and short-term investments of ¥4.0B.
Key information
14.3%
Debt to equity ratio
JP¥1.60b
Debt
Interest coverage ratio | 267.5x |
Cash | JP¥3.98b |
Equity | JP¥11.18b |
Total liabilities | JP¥5.50b |
Total assets | JP¥16.68b |
Recent financial health updates
No updates
Recent updates
Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 21Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return
Mar 29Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain
Feb 11Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?
Dec 24Financial Position Analysis
Short Term Liabilities: 9776's short term assets (¥7.7B) exceed its short term liabilities (¥3.3B).
Long Term Liabilities: 9776's short term assets (¥7.7B) exceed its long term liabilities (¥2.2B).
Debt to Equity History and Analysis
Debt Level: 9776 has more cash than its total debt.
Reducing Debt: 9776's debt to equity ratio has increased from 0% to 14.3% over the past 5 years.
Debt Coverage: 9776's debt is well covered by operating cash flow (67.4%).
Interest Coverage: 9776's interest payments on its debt are well covered by EBIT (267.5x coverage).